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A bs tr ac t
Background
In the spring of 2009, an outbreak of severe pneumonia was reported in conjunc-
tion with the concurrent isolation of a novel swine-origin influenza A (H1N1) virus 
(S-OIV), widely known as swine flu, in Mexico. Influenza A (H1N1) subtype viruses 
have rarely predominated since the 1957 pandemic. The analysis of epidemic pneu-
monia in the absence of routine diagnostic tests can provide information about risk 
factors for severe disease from this virus and prospects for its control.
Methods
From March 24 to April 29, 2009, a total of 2155 cases of severe pneumonia, involv-
ing 821 hospitalizations and 100 deaths, were reported to the Mexican Ministry of 
Health. During this period, of the 8817 nasopharyngeal specimens that were submitted 
to the National Epidemiological Reference Laboratory, 2582 were positive for S-OIV. 
We compared the age distribution of patients who were reported to have severe pneu-
monia with that during recent influenza epidemics to document an age shift in rates 
of death and illness.
Results
During the study period, 87% of deaths and 71% of cases of severe pneumonia in-
volved patients between the ages of 5 and 59 years, as compared with average rates of 
17% and 32%, respectively, in that age group during the referent periods. Features 
of this epidemic were similar to those of past influenza pandemics in that circula-
tion of the new influenza virus was associated with an off-season wave of disease af-
fecting a younger population.
Conclusions
During the early phase of this influenza pandemic, there was a sudden increase in the 
rate of severe pneumonia and a shift in the age distribution of patients with such 
illness, which was reminiscent of past pandemics and suggested relative protection 
for persons who were exposed to H1N1 strains during childhood before the 1957 
pandemic. If resources or vaccine supplies are limited, these findings suggest a ratio-
nale for focusing prevention efforts on younger populations.
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In early April 2009, a sharp increase in reports of patients requiring hospitalization for pneumonia and an unusual series of deaths 
were reported to the Mexican Ministry of Health. 
The National Epidemiological Surveillance System 
(SINAVE), a nationwide interagency system led by 
the Directorate General of Epidemiology,1 noted a 
particular increase among adults between the ages 
of 20 and 40 years and an increase in cases of lab-
oratory-confirmed influenza. Typically, in Mex-
ico, seasonal influenza is observed from October 
through March,2 with an appreciable increase in 
the rate of death among the elderly,3 similar to 
the pattern observed in other temperate climates, 
such as the United States.4,5 The concurrent find-
ing of a swine-origin influenza A (H1N1) virus 
(S-OIV)6 from infected children in the United 
States7 prompted a rapid response from the Mex-
ican public health emergency system.
From March 24 through April 29, 2009, there 
were reports of 2155 cases of severe pneumonia, 
including 100 deaths, to the SINAVE system in 
response to requests for data on patients who had 
required hospitalization for severe pneumonia. 
During this period, of the 8817 nasopharyngeal 
specimens that were submitted to the National 
Epidemiological Reference Laboratory, 3664 (42%) 
tested positive for influenza subtype A; of these 
specimens, 2582 (70%) were confirmed as S-OIV 
by reverse-transcriptase–polymerase-chain-reaction 
(PCR) assay.
In this article, we evaluate the reported case 
series of severe pneumonia and compare the age 
patterns with respect to morbidity and mortality 
with patterns from recent influenza epidemics in 
Mexico. Crucial epidemiologic factors, such as the 
age pattern of morbidity and mortality during the 
2009 epidemic, are inferred because of the limited 
availability of diagnostic tests and data. Given the 
relatively rapid global spread of this newly de-
scribed pathogen,8 early identification of groups 
at risk for severe pneumonia can aid in prioritiz-
ing the use of vaccines and antiviral drugs in the 
face of limited supplies.
Me thods
Epidemiologic Surveillance
The SINAVE was established in September 1995 
to harmonize surveillance procedures nationally. 
SINAVE receives weekly reports of 117 notifiable 
conditions from 19,715 of 20,472 (96%) public and 
private primary care clinics and hospitals in Mex-
ico. Since 2006, surveillance of influenza-like ill-
ness with testing for influenza virus has been con-
ducted in sentinel units in all 32 states, increasing 
from 380 sentinel units in 2006 to 520 in 2008. 
Influenza-like illness is defined as fever, cough, 
and headache, accompanied by one or more of the 
following signs or symptoms: rhinorrhea, coryza, 
arthralgia, myalgia, prostration, odynophagia, 
chest pain, abdominal pain, and nasal congestion. 
Nasopharyngeal swabs are taken from a propor-
tion of patients and processed with the use of an 
immunofluorescence assay for influenza. Positive 
specimens are then sent to the National Epide-
miological Reference Laboratory for PCR testing. 
The proportion of specimens that are confirmed 
as positive typically ranges from 7.5 to 9.0% dur-
ing influenza season.
On April 14 and April 15, 2009, the Mexican 
Ministry of Health received notification from sev-
eral cities of cases of severe pneumonia affecting 
mostly young persons, coupled with an increase 
in the number of cases and outbreaks of seasonal 
influenza observed since February. Responding to 
this situation, on April 17, the Ministry of Health 
issued an epidemiologic alert and requested that 
medical institutions in all Mexican states intensify 
notification regarding patients requiring hospital-
ization for pneumonia through an Internet-based 
platform. Individual case records were reported 
online to the SINAVE, including the date of the 
onset of symptoms, the date of hospitalization, the 
institution reporting the case, and the patient’s age, 
sex, and state of residence. Since influenza season 
normally ends in March, few of the original sam-
ples from patients during this period had under-
gone laboratory testing to diagnose in fluenza.
Study Period
Without knowing when the index case of S-OIV 
infection occurred, we defined the study period as 
the interval from the date of the onset of symp-
toms in the patient with the earliest suspected case 
of atypical pneumonia (March 24) to April 29, when 
selective reporting of severe pneumonia ceased. 
We reviewed the records of 2155 patients with se-
vere pneumonia in the database. Of these records, 
821 (38%) indicated a date of hospitalization for 
pneumonia, and 100 (5%) involved deaths of pa-
tients. Although the SINAVE system captured only 
a portion of all hospitalizations for pneumonia, 
it provided the best data currently available on the 
rate of increase in severe pneumonia during this 
period.
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From national registries we obtained data on 
age-specific cases of pneumonia and influenza and 
corresponding deaths during the peak of seasonal 
influenza periods from 2005 through 2008.9 Since 
there may be underreporting in the SINAVE and we 
do not expect systematic reporting bias according 
to age, we compared the proportion of patients in 
each age group between the study period and the 
previous periods of seasonal influenza.
R esult s
The time series of laboratory-confirmed influen-
za for the Federal District and all of Mexico from 
2005 through April 2009 is shown in Figure 1. 
Peak epidemic periods that were used as a base-
line occurred in November and December, Janu-
ary through March, and November through Feb-
ruary during three preceding influenza seasons 
(2005 through 2008). The influenza season in the 
Federal District coincided with the rest of the coun-
try for the greater part of that period.
The percentage age distributions for mortality 
(Fig. 2) and morbidity (Fig. 3) for all patients with 
severe pneumonia during the 2009 outbreak show 
a marked shift to persons between the ages of 
5 and 59 years, as compared with distributions 
observed during previous periods of epidemic 
influenza. Similar results were observed for the 
data restricted to the Federal District.
The reported shift in the proportion of young 
adults who died from pneumonia is readily ob-
served in the data for the study period, as com-
pared with previous influenza seasons (Fig. 2). 
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Figure 1. Time Series of Confirmed Cases of Influenza in the Federal District and in All of Mexico, According to Month (January 2005– 
April 2009).
Data are from the National Epidemiological Reference Laboratory.
The New England Journal of Medicine 
Downloaded from nejm.org at GEORGIA STATE UNIVERSITY LIBRARY on December 7, 2015. For personal use only. No other uses without permission. 
 Copyright © 2009 Massachusetts Medical Society. All rights reserved. 
Severe Respir atory Disease Concurrent with H1N1 Influenza
n engl j med 361;7 nejm.org august 13, 2009 677
Percentage increases in death were seen in sub-
groups of patients between the ages of 5 and 59 
years, representing 87% of deaths from severe 
pneumonia during the study, as compared with 
17% on average during previous epidemic periods. 
Percentage increases ranged from a factor of 1.2 
to a factor of 11.7, with percentage decreases in 
the subgroup of patients under 4 years of age 
(0.3) and in subgroups of patients 60 years of age 
or older (0 to 0.3) (Table 1). Shifts in morbidity 
were pronounced, with 71% of cases of severe 
pneumonia occurring in patients between the ages 
of 5 and 59 years, as compared with an average 
of 32% of cases in that age group during the ref-
erent periods (Fig. 3).
Discussion
These data show a sudden increase in the rate of 
severe pneumonia and a shift in the age distribu-
tion of patients with such illness, which were con-
current with person-to-person circulation of S-OIV 
infection in Mexico. Although the epidemiologic, 
clinical, and virologic characteristics of this out-
break are evolving, this wave of pneumonia is rem-
iniscent of the initial phase of pandemics from 
the last century.10 These factors include the docu-
mentation of a novel pathogenic influenza virus 
and a shift in the ages of patients who become ill 
or die.11 Early waves of respiratory illness in young 
adults were observed before the 1918 influenza 
pandemic in New York,12 Copenhagen,13 the United 
Kingdom,14 and Geneva,15 as well as among mem-
bers of the U.S. military.16 The apparent popula-
tion effect of S-OIV infection has several signa-
ture features17 of previous pandemics, including 
atypical timing and age shifts in disease severity.
Case ascertainment for the specific diagnosis 
of S-OIV infection has been limited, given the lack 
of commercially available tests for this virus and 
the scarcity of reagents in the setting of an evolv-
ing global epidemic. We address this challenge 
through analyses of data before, during, and after 
the initial acceleration of reporting activities, as 
well as through stratification according to region. 
We have also compared the data with those ob-
tained during periods of seasonal epidemic in-
fluenza. Given variable underreporting, we have 
based our comparisons on proportionate distri-
butions. Unless there are systemic biases in report-
ing according to age group, this approach provides 
a reasonable approach for comparison.
Although many cases of severe pneumonia have 
not yet been confirmed as S-OIV infection through 
laboratory diagnoses, given the limited availabil-
ity of specific assays for the new pathogen, the 
proportional increase in incidence among younger 
adults and the high proportion of patients with 
confirmed S-OIV infection (44%) lead us to be-
lieve that a large proportion of the reported cases 
are probably associated with this novel pathogen. 
A similar study that was performed in Denmark 
during the 1918 outbreak indicated that during a 
wave of atypical pneumonia, there was an increase 
by a factor of 20 in incidence, as compared with 
that in preceding years, which implied that influ-
enza was the putative agent.13
Influenza A (H1N1) viruses were in circulation 
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Figure 2. Percentage Distribution of Deaths from Severe Pneumonia  
during the 2009 Study Period, as Compared with Influenza Seasons  
from 2006 through 2008, in Mexico, According to Age Group.
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Figure 3. Percentage Distribution of Illness from Severe Pneumonia  
during the 2009 Study Period, as Compared with Influenza Seasons  
from 2005 through 2008, in Mexico, According to Age Group.
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from 1918 through 1957, and genetically similar 
isolates, most likely representing a laboratory es-
cape, reemerged in 1977 to periodically cocircu-
late with A (H3N2) subtypes. In 1976, a limited 
number of swine-influenza cases set off a mas-
sive vaccine campaign to control a potential pan-
demic, which fortunately never occurred. How-
ever, unlike the situation in 1976, epidemiologic 
evidence from this outbreak indicates that there 
were continuous chains of person-to-person trans-
mission for several viral generations. Since the 
discovery of influenza viruses, the past two in-
fluenza pandemics have been characterized by 
novel subtypes. Although humans have previously 
been exposed to the influenza A (H1N1) subtype, 
this novel virus has made a host-species jump with 
sustained human-to-human transmission.
In 1918, patients who were documented with 
illness during the early waves of severe pneumo-
nia in Denmark and among members of the U.S. 
military were less likely to be ill in the later wave 
of the pandemic,13,16 which suggests the possibil-
ity of natural infection with a less virulent but an-
tigenically similar virus in the general population. 
It is unclear whether this circulating virus would 
have a similar effect if it recirculated after the ini-
tial wave. Likewise, childhood exposure to influ-
enza A (H1N1) viruses in persons who were born 
before 1957, when these viruses circulated widely, 
may have conferred some level of protection.
Of note, during the study period, there was 
proportionately lower morbidity among persons 
who were 60 years of age or older, the age group 
in which all persons were born before the 1957 
pandemic. With an annual influenza incidence of 
15 to 20%, most of these persons would have been 
first exposed to influenza A (H1N1) strains, which 
disappeared from circulation after the 1957 A 
(H2N2) influenza pandemic. Francis described the 
concept of “original antigenic sin,” in which the 
immune response is greatest to antigens to which 
first exposure occurred in childhood.18 According 
to this concept, persons born before 1957 who 
were exposed in childhood to influenza A (H1N1) 
viruses might be better protected against this vi-
ral subtype than those who were first exposed to 
other influenza A subtypes, H2N2 and H3N2, at 
a later date. Age shifts in mortality to younger 
populations during pandemics have been described 
from the reemergence of a subtype.19 Although 
persons who were born after 1977 may have been 
first exposed to an influenza A (H1N1) subtype 
virus, such strains rarely predominate. In this data 
series, persons who were 60 years of age or older 
were proportionately less likely to have severe 
pneumonia, a consideration for future strategies 
for vaccine allocation.20
An early wave of influenza in northern England 
during the 1951 influenza season was document-
ed with even higher mortality than that of the 
1918 pandemic, but the situation never evolved into 
a pandemic.21 Similarly, the public health commu-
nity acted swiftly to develop a vaccine in response 
to human cases of swine influenza in 1976, and a 
pandemic did not occur.22 During the early phase 
of this epidemic, the rapid identification of per-
sons who are likely to have severe disease, as 
compared with those who are likely to have mild 
disease, can guide epidemic or pandemic re-
sponse strategies. Our outline of the age-strati-
fication profile of risk provides a possible foun-
dation for control strategies on the basis of the 
Table 1. Proportion of Mortality from Severe Pneumonia According to Age 
Group during the 2009 Study Period, as Compared with Influenza Seasons 
from 2006 through 2008, in Mexico.* 
Age Group Mortality
2006–2008 Influenza 
Seasons
March 24 to 
April 29, 2009
Ratio, Study Period 
to Referent Period
yr percent
0–4 17 5 0.3
5–9 1 5 7.6
10–14 1 6 10.7
15–19 1 7  8.6
20–24 1 13 11.7
25–29 1 11 10.3
30–34 1 9  6.0
35–39 2 15  9.4
40–44 2 9  4.8
45–49 2 5 2.1
50–54 2 4 1.6
55–59 3 3 1.2
60–64 3 0 0.0
65–69 5 1 0.2
70–74 7 2 0.3
75–79 9 2 0.2
≥80 42 3 0.1
* Data were reported by the National System of Health Care Information and 
the National Epidemiological Surveillance System (SINAVE). 
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biologic plausibility of partial protection from 
earlier exposure. Further studies are under way 
in Mexico to elucidate other potential risk factors 
for severity of S-OIV infection to guide targeted 
control efforts.
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